Lv79
4710 积分 2024-01-08 加入
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
5天前
已完结
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
8天前
已完结
BTKi-induced cardiovascular toxicity in CLL: Risk mitigation and management strategies
18天前
已完结
MRD-driven treatment strategies in CLL: Current practice, limitations, and emerging paradigms
27天前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
1个月前
已完结
Chronic lymphocytic leukaemia
1个月前
已完结
From R-CHOP to revolution: How CAR T-Cells, ADCs, and bispecific antibodies are transforming DLBCL treatment
2个月前
已完结
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
2个月前
已完结
Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progress
2个月前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
